- Home
- AIN vs EWTX Comparison
AIN vs EWTX Comparison
Compare AIN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIN
- EWTX
- Stock Information
- Founded
- AIN 1895
- EWTX 2017
- Country
- AIN United States
- EWTX United States
- Employees
- AIN N/A
- EWTX N/A
- Industry
- AIN Textiles
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- AIN Consumer Discretionary
- EWTX Health Care
- Exchange
- AIN Nasdaq
- EWTX Nasdaq
- Market Cap
- AIN 2.5B
- EWTX 2.7B
- IPO Year
- AIN 1987
- EWTX 2021
- Fundamental
- Price
- AIN $80.28
- EWTX $30.11
- Analyst Decision
- AIN Buy
- EWTX Buy
- Analyst Count
- AIN 4
- EWTX 6
- Target Price
- AIN $82.75
- EWTX $44.83
- AVG Volume (30 Days)
- AIN 254.5K
- EWTX 762.1K
- Earning Date
- AIN 10-30-2024
- EWTX 11-07-2024
- Dividend Yield
- AIN 1.30%
- EWTX N/A
- EPS Growth
- AIN 1.31
- EWTX N/A
- EPS
- AIN 3.20
- EWTX N/A
- Revenue
- AIN $1,267,294,000.00
- EWTX N/A
- Revenue This Year
- AIN $9.42
- EWTX N/A
- Revenue Next Year
- AIN $4.54
- EWTX N/A
- P/E Ratio
- AIN $25.06
- EWTX N/A
- Revenue Growth
- AIN 15.93
- EWTX N/A
- 52 Week Low
- AIN $67.39
- EWTX $8.00
- 52 Week High
- AIN $99.41
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- AIN 49.94
- EWTX 46.80
- Support Level
- AIN $79.92
- EWTX $27.00
- Resistance Level
- AIN $83.06
- EWTX $35.50
- Average True Range (ATR)
- AIN 1.86
- EWTX 2.36
- MACD
- AIN -0.41
- EWTX -0.10
- Stochastic Oscillator
- AIN 24.29
- EWTX 38.94
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.